Products for Research Use Only
RegisterLogin

NSC 850745

CAT: 0804-HY-175848Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-175848Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
NSC 850745 is a selective and potent c-Met/STAT3 inhibitor with IC50 values of 210 and 670 nM. NSC 850745 can inhibit cell proliferation, induce G2/M phase arrest and induce apoptosis. NSC 850745 can downregulate AKT-1, VEGF and Bcl-2 expression and upregulate p53, Bax and caspase expression. NSC 850745 can be used for the research of cancer, such as leukemia and colon cancer[1].
UNSPSC
12352005
Target
Akt; Apoptosis; Bcl-2 Family; Caspase; c-Met/HGFR; MDM-2/p53; STAT; VEGFR
Related Pathways
Apoptosis; JAK/STAT Signaling; PI3K/Akt/mTOR; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Field of Research
Cancer
Smiles
O=C(CN1CCN(CC1)C2=C3C(N(N=C3)C4=CC=CC=C4)=NC=N2)NCC5=CC=CC=C5
Molecular Formula
C24H25N7O
Molecular Weight
427.50
References & Citations
[1]El-Desouky SI, et al. Scaffold-hopping strategy for pyrazolo[3,4-d]pyrimidines: In vitro and in silico studies of dual c-Met/STAT3 inhibition for enhanced antitumor activity. Bioorg Chem. 2025 Sep;164:108821.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Akt1; Bcl-2; Caspase 3; Caspase 8; Caspase 9; Met; STAT3

Related Products

CatalogName
HY-171152NSC 357754
HY-105293NSC 727357
HY-22159-01NSC 409012
HY-160638-01NSC-311068
HY-141687-01NSC 107512
HY-152168-01NSC 295642
HY-119172-01NSC-60339
HY-15480-01NSC 42834
HY-B1714A-01NSC 601980
HY-Y0057-01NSC 13138

Alternative Products

CatalogName
GTR19273021-01NSC 850745

Popular Products